DK121440B - Analogifremgangsmåde til fremstilling af 2,4-bis-morpholino- eller-thiomorpholino-5-carbalkoxy-pyrimidiner. - Google Patents

Analogifremgangsmåde til fremstilling af 2,4-bis-morpholino- eller-thiomorpholino-5-carbalkoxy-pyrimidiner.

Info

Publication number
DK121440B
DK121440B DK591669AA DK591669A DK121440B DK 121440 B DK121440 B DK 121440B DK 591669A A DK591669A A DK 591669AA DK 591669 A DK591669 A DK 591669A DK 121440 B DK121440 B DK 121440B
Authority
DK
Denmark
Prior art keywords
carbalkoxy
thiomorpholino
pyrimidines
morpholino
bis
Prior art date
Application number
DK591669AA
Other languages
English (en)
Inventor
E Wyss
Original Assignee
Wander Ag Dr A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1667968A external-priority patent/CH506550A/de
Priority claimed from CH303969A external-priority patent/CH514618A/de
Priority claimed from CH1185769A external-priority patent/CH518303A/de
Application filed by Wander Ag Dr A filed Critical Wander Ag Dr A
Publication of DK121440B publication Critical patent/DK121440B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
DK591669AA 1968-11-08 1969-11-07 Analogifremgangsmåde til fremstilling af 2,4-bis-morpholino- eller-thiomorpholino-5-carbalkoxy-pyrimidiner. DK121440B (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1667968A CH506550A (de) 1968-11-08 1968-11-08 Verfahren zur Herstellung von Pyrimidin-Derivaten
CH303969A CH514618A (de) 1969-02-28 1969-02-28 Verfahren zur Herstellung von Pyrimidin-Derivaten
CH1185769A CH518303A (de) 1969-08-05 1969-08-05 Verfahren zur Herstellung von Pyrimidin-Derivate

Publications (1)

Publication Number Publication Date
DK121440B true DK121440B (da) 1971-10-18

Family

ID=27174089

Family Applications (1)

Application Number Title Priority Date Filing Date
DK591669AA DK121440B (da) 1968-11-08 1969-11-07 Analogifremgangsmåde til fremstilling af 2,4-bis-morpholino- eller-thiomorpholino-5-carbalkoxy-pyrimidiner.

Country Status (14)

Country Link
US (1) US3635962A (da)
AT (1) AT307433B (da)
BE (1) BE741376A (da)
DE (1) DE1955318A1 (da)
DK (1) DK121440B (da)
ES (1) ES373237A1 (da)
FR (1) FR2024819B1 (da)
GB (1) GB1270120A (da)
IE (1) IE33364B1 (da)
IL (1) IL33321A (da)
NL (1) NL6916269A (da)
NO (1) NO124209B (da)
OA (1) OA03165A (da)
RO (5) RO57209A (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT340933B (de) * 1973-08-20 1978-01-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
HUP0400405A3 (en) 2004-02-10 2009-03-30 Sanofi Synthelabo Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates

Also Published As

Publication number Publication date
OA03165A (fr) 1970-12-15
ES373237A1 (es) 1971-12-16
IE33364L (en) 1970-05-08
FR2024819B1 (da) 1974-08-30
IL33321A (en) 1972-02-29
IL33321A0 (en) 1970-01-29
RO57597A (da) 1974-12-15
BE741376A (da) 1970-05-06
DE1955318A1 (de) 1970-06-04
NL6916269A (da) 1970-05-12
RO57208A (da) 1974-12-15
NO124209B (da) 1972-03-20
RO57210A (da) 1975-01-15
FR2024819A1 (da) 1970-09-04
RO55872A (da) 1974-02-01
RO57209A (da) 1974-11-11
GB1270120A (en) 1972-04-12
IE33364B1 (en) 1974-05-29
US3635962A (en) 1972-01-18
AT307433B (de) 1973-05-25

Similar Documents

Publication Publication Date Title
DK132174B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
DK123589B (da) Fremgangsmåde til fremstilling af 2,3,6-trimethylphenol.
DK120439B (da) Fremgangsmåde til fremstilling af 1,5-disubstituerede 4-cyanopyrazoler.
DK118877B (da) Analogifremgangsmåde til fremstilling af 3,1-benzoxazin-2-oner.
DK125091B (da) Fremgangsmåde til fremstilling af 1-hydroxy-2-pyridoner.
DK140842B (da) Fremgangsmåde til fremstilling af 8,9-didebydro-10alfa-alkoxy-ergolener.
DK125852B (da) Fremgangsmåde til fremstilling af erythromycylamin.
DK133430B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-aroylpyrrolidiner.
DK122124B (da) Fremgangsmåde til fremstilling af 2-acyloxythionobenzamider.
DK123232B (da) Analogifremgangsmåde til fremstilling af 3-alkoxy-17α-propinylestra-1,3,5(10)-trien-17β-oler.
DK123236B (da) Fremgangsmåde til fremstilling af 2-alkyl-3-hydoxy-4,5-dihydrofuran-4-oner.
DK123300B (da) Analogifremgangsmåde til fremstilling af thiophen-3-isonitriler.
DK121956B (da) Analogifremgangsmåde til fremstilling af 1,2,4-oxadiazolderivater.
DK121052B (da) Fremgangsmåde til fremstilling af steroid-17α,21-orthocarbonater.
DK125464C (da) Analogifremgangsmåde til fremstilling af 6-halogen-15β, 16β-methylen-pregnanderivater.
DK128008B (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK123353B (da) Analogifremgangsmåde til fremstilling af 6,7-methylen-20-spirox-4-en-3-on-forbindelser.
DK122129B (da) Analogifremgangsmåde til fremstilling af N,N'-dialkyl-4-phenylimidazolin-2-thioner.
DK123239B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-4,4-dialkylquinazoliner.
DK126654B (da) Analogifremgangsmåde til fremstilling af 2-hydroxymethyl-3-carboxylsyreamido-quinoxalin-di-N-oxider-(1,4).
DK127812B (da) Analogifremgangsmåde til fremstilling af 3,5-dibrom-zearalan.
DK123818B (da) Fremgangsmåde til fremstilling af 14β-hydroxy-card-20(22)-enolider eller -bufa-20,20-dienolider.
DK124331B (da) Analogifremgangsmåde til fremstilling af 14β-hydroksy-15α-acyloksy-4,20(22)-kardadienolider.
DK122816B (da) Analogifremgangsmåde til fremstilling af 3-aryl-5-methylhydantoiner.
DK140284B (da) Analogifremgangsmåde til fremstilling af oxazinobenzodiazepiner.